These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 26266114

  • 1. Fibrinolytic Activity of Blood and its Determinants in Healthy Medical Students.
    Siddqui NI, Shoeb M, Bose S.
    J Clin Diagn Res; 2015 Jun; 9(6):CC05-7. PubMed ID: 26266114
    [Abstract] [Full Text] [Related]

  • 2. The fibrinolytic potential in patients with Cushing's disease: a clue to their hypercoagulable state.
    Patrassi GM, Sartori MT, Viero ML, Scarano L, Boscaro M, Girolami A.
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):789-93. PubMed ID: 1489900
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Impaired fibrinolysis in hypertension and obesity due to high plasminogen activator inhibitor-1 level in plasma.
    Urano T, Kojima Y, Takahashi M, Serizawa K, Sakakibara K, Takada Y, Takada A.
    Jpn J Physiol; 1993 Dec; 43(2):221-8. PubMed ID: 8355419
    [Abstract] [Full Text] [Related]

  • 6. Hemostatic status and fibrinolytic response potential at different phases of the menstrual cycle.
    Koh SC, Prasad RN, Fong YF.
    Clin Appl Thromb Hemost; 2005 Jul; 11(3):295-301. PubMed ID: 16015415
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].
    Ihnken K, Speiser W, Müller-Berghaus G, Beyersdorf F, Schlepper M, Satter P.
    Helv Chir Acta; 1992 Jan; 58(4):503-8. PubMed ID: 1582860
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reduced fibrinolytic activity in coronary heart disease in basal conditions and after exercise.
    Estellés A, Tormo G, Aznar J, España F, Tormo V.
    Thromb Res; 1985 Nov 01; 40(3):373-83. PubMed ID: 4082114
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding.
    Gleeson NC, Buggy F, Sheppard BL, Bonnar J.
    Acta Obstet Gynecol Scand; 1994 Mar 01; 73(3):274-7. PubMed ID: 8122512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.